NCT03578796View on ClinicalTrials.gov

Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study

Active, not recruitingOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2026

Conditions
Amyotrophic Lateral SclerosisCognitive Impairment
Interventions
DIAGNOSTIC_TEST

ECAS-N

assessing ALS-specific cognitive impairment

DIAGNOSTIC_TEST

MoCA

assessing cognitive impairment

DIAGNOSTIC_TEST

CDR

assessing global cognitive impairment, as well as possible diagnosis- and Level of dementia

OTHER

Questionnaire

Questions related to work situation and car driving

Trial Locations (1)

5021

Haukeland University Hospital, Bergen

All Listed Sponsors
collaborator

Western Norway University of Applied Sciences

OTHER

lead

Haukeland University Hospital

OTHER

NCT03578796 - Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study | Biotech Hunter | Biotech Hunter